1-7 of 7
Cary P Gross, MD
Close
Sort by
Journal Articles

Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States

Scott F. Huntington, MD MPH, Pamela R. Soulos, Paul M. Barr, MD, Ryan Jacobs, MD, Frederick Lansigan, MD, Oreofe O. Odejide, MD MPH, Lee S. Schwartzberg, MD, Amy J. Davidoff, PhD MS, Cary P Gross, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 797.
https://doi.org/10.1182/blood-2019-122054
Published: 2019
Journal Articles

Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility

Scott F Huntington, MD MPH, Weiwei Zhu, MPH, Jessica Hoag, PhD, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Cary P Gross, MD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3538.
https://doi.org/10.1182/blood-2018-99-115140
Published: 2018
Journal Articles

Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States

Scott Huntington, MDMPH, Jessica Hoag, PhD, Weiwei Zhu, Ms, Cary P Gross, MD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2120.
https://doi.org/10.1182/blood.V130.Suppl_1.2120.2120
Published: 2017
Journal Articles

Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based Study

Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Pamela R Soulos, MPH, James B. Yu, MD, Amy J. Davidoff, PhD, Steven D. Gore, MD, Cary P. Gross, MD, Xiaomei Ma, PhD
Journal: Blood
Blood (2015) 126 (23): 3295.
https://doi.org/10.1182/blood.V126.23.3295.3295
Published: 2015
Journal Articles

Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Amer M. Zeidan, MBBS, MHS, Jessica B. Long, PhD, Jane Hall, Rong Wang, PhD, Scott F Huntington, MDMPH, Gregory Abel, MD MPH, Thomas Prebet, MD, Nikolai A. Podoltsev, MDPhD, Cary P. Gross, MD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD
Journal: Blood
Blood (2015) 126 (23): 3285.
https://doi.org/10.1182/blood.V126.23.3285.3285
Published: 2015
Journal Articles

Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US)

Amer M. Zeidan, MBBS, MHS, Rong Wang, PhD, Amy J. Davidoff, PhD, Steven D. Gore, MD, Pamela R Soulos, MPH, Scott F Huntington, MDMPH, Cary P. Gross, MD, Xiaomei Ma, PhD
Journal: Blood
Blood (2015) 126 (23): 873.
https://doi.org/10.1182/blood.V126.23.873.873
Published: 2015
Journal Articles

Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study

Amer M. Zeidan, MBBS, MHS, Jessica B. Long, PhD, Rong Wang, PhD, James B. Yu, MD, Jane Hall, Gregory Abel, MD MPH, Steven D. Gore, MD, Cary P. Gross, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD
Journal: Blood
Blood (2015) 126 (23): 1676.
https://doi.org/10.1182/blood.V126.23.1676.1676
Published: 2015